Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Li

Showing results (111-120 of 276) with videos related to

Pageof 28
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Migraine in postmenopausal women and the risk of invasive breast cancerRobert W Mathes, Kathleen E Malone, Janet R Daling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancerJustin E Mirus, Yuzheng Zhang, Christopher I Li, et al.
Breast Cancer Research and Treatment|April 26, 2008
Population-based estimates of the relation between breast cancer risk, tumor subtype, and family historyMegan L Welsh, Diana S M Buist, Erin J Aiello Bowles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2016
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysisAlbert J Farias, India J Ornelas, Sarah D Hohl, et al.
Journal of the National Cancer Institute|April 30, 2014
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 statusNadia Howlader, Sean F Altekruse, Christopher I Li, et al.
Progress in Community Health Partnerships : Research, Education, and Action|June 2, 2017
Engaging Study Participants in Research Dissemination at a Center for Population Health and Health DisparitiesSarah Knerr, Sarah D Hohl, Yamile Molina, et al.
Breast Cancer Research and Treatment|May 26, 2016
Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancerLu Chen, Linda S Cook, Mei-Tzu C Tang, et al.
Cancer Causes & Control : CCC|December 25, 2010
Reproductive history and risk of three breast cancer subtypes defined by three biomarkersAmanda I Phipps, Diana S M Buist, Kathleen E Malone, et al.
Breast Cancer Research and Treatment|September 4, 2010
Family history of breast cancer in first-degree relatives and triple-negative breast cancer riskAmanda I Phipps, Diana S M Buist, Kathleen E Malone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 18, 2014
Oral contraceptives and breast cancer risk overall and by molecular subtype among young womenElisabeth F Beaber, Kathleen E Malone, Mei-Tzu Chen Tang, et al.
Pageof 28

Showing results (111-120 of 276) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Migraine in postmenopausal women and the risk of invasive breast cancerRobert W Mathes, Kathleen E Malone, Janet R Daling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancerJustin E Mirus, Yuzheng Zhang, Christopher I Li, et al.
Breast Cancer Research and Treatment|April 26, 2008
Population-based estimates of the relation between breast cancer risk, tumor subtype, and family historyMegan L Welsh, Diana S M Buist, Erin J Aiello Bowles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2016
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysisAlbert J Farias, India J Ornelas, Sarah D Hohl, et al.
Journal of the National Cancer Institute|April 30, 2014
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 statusNadia Howlader, Sean F Altekruse, Christopher I Li, et al.
Progress in Community Health Partnerships : Research, Education, and Action|June 2, 2017
Engaging Study Participants in Research Dissemination at a Center for Population Health and Health DisparitiesSarah Knerr, Sarah D Hohl, Yamile Molina, et al.
Breast Cancer Research and Treatment|May 26, 2016
Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancerLu Chen, Linda S Cook, Mei-Tzu C Tang, et al.
Cancer Causes & Control : CCC|December 25, 2010
Reproductive history and risk of three breast cancer subtypes defined by three biomarkersAmanda I Phipps, Diana S M Buist, Kathleen E Malone, et al.
Breast Cancer Research and Treatment|September 4, 2010
Family history of breast cancer in first-degree relatives and triple-negative breast cancer riskAmanda I Phipps, Diana S M Buist, Kathleen E Malone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 18, 2014
Oral contraceptives and breast cancer risk overall and by molecular subtype among young womenElisabeth F Beaber, Kathleen E Malone, Mei-Tzu Chen Tang, et al.
Pageof 28